RT @jasonlukemd: 4 #melanoma subtypes: BRAF, RAS, NF1 and triple WT. Exited 2 b leading @theNCI MATCH trial arm 4 trametinib in NF1! https:…

10:03am June 19th 2015 via Twitter Web Client